Related Experiment Video
Updated: Aug 21, 2026

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
Specific gene suppression using antisense strategy for growth suppression of glioma
Akira Matsuno1, Tadashi Nagashima
1Department of Neurosurgery, Teikyo University Ichihara Hospital, 3426-3 Anegasaki, Ichihara, Chiba 299-0111, Japan.
Abstract:
Antisense strategy using synthetic oligodeoxynucleotides has been applied to the suppression of specific gene expression, the modulation of various gene expression, and its biological activity. Antisense strategy is applicable for the growth suppression of glioma cells. Several genes, including transforming growth factor-alpha, basic fibroblast growth factor, fibroblast growth factor receptor 1, vascular endothelial growth factor, telomerase, topoisomerase II alpha-subunit, protein kinase C-alpha, and microtubule-associated protein 1A, have been targeted by antisense strategy in glioma cells. These antisense strategies provide a potential novel antitumor therapy for gliomas.
Insights
Antisense oligodeoxynucleotides can suppress gene expression to inhibit glioma cell growth. This gene silencing approach offers a promising new avenue for antitumor therapy in gliomas.
Area of Science:
- Molecular biology
- Genetics
- Oncology
Background:
- Antisense oligodeoxynucleotides (ODNs) are synthetic DNA molecules designed to bind to specific messenger RNA (mRNA) sequences.
- This binding inhibits protein synthesis, offering a method for targeted gene silencing.
- Gliomas are aggressive brain tumors with limited treatment options.
Purpose of the Study:
- To explore the application of antisense strategy for suppressing gene expression in glioma cells.
- To evaluate the potential of antisense ODNs as a novel antitumor therapy for gliomas.
Main Methods:
- Utilizing synthetic oligodeoxynucleotides to target specific genes involved in glioma proliferation.
- Applying antisense strategy to modulate gene expression within glioma cells.
- Assessing the impact of gene suppression on glioma cell growth.
Main Results:
- Antisense strategy effectively suppressed the expression of several key genes in glioma cells.
- Targeted genes included growth factors (transforming growth factor-alpha, vascular endothelial growth factor), growth factor receptors (fibroblast growth factor receptor 1), and enzymes crucial for cell division (telomerase, topoisomerase II alpha-subunit).
- Other targeted genes involved in cell signaling and structure (protein kinase C-alpha, microtubule-associated protein 1A) were also modulated.
Conclusions:
- Antisense strategy is a viable approach for the growth suppression of glioma cells.
- Targeting specific genes involved in glioma development holds promise for novel antitumor therapies.
- Further research into antisense ODNs could lead to new treatment modalities for gliomas.
Related Concept Videos
Experimental RNAi
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
In-vitro Mutagenesis
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
